Skip to Content

View Additional Section Content

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome (AEGIS-II Study)

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03473223?term=aegis-ii&rank=1

Clinical Trial Categories

  • Cardiology
Contact
Matthew G. Dreese, MS at 215-481-4193

Location

  • Abington Medical Specialists

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926